Information Technology
Appen Ltd (APX)
Appen provides data annotation and AI training services to major technology companies.
Market Cap
A$390M
Shares on Issue
0.12B
Price Chart
AI Analysis
Appen is restructuring to stabilise revenue after demand shifts from large platform clients. Diversification into enterprise AI data solutions is a strategic focus.
Margins may remain under pressure until volumes improve, but operational reforms could rebuild competitiveness over time.
Bull Case
- • AI data demand rebound could lift revenue.
- • Enterprise diversification reduces client concentration.
- • Cost restructuring can improve margins.
Bear Case
- • Client concentration remains a risk.
- • Pricing pressure in AI data services.
- • Revenue volatility impacts cash flow.
Market Sentiment
Based on 35 social posts
Recent mentions
Analysis failed
Analysis failed
Analysis failed
Recent Announcements
Change of Director's Interest Notice - Mr Ryan Kolln
Application for quotation of securities - APX
Appendix 4G & Corporate Governance Statement
Investor Presentation
FY25 Results and FY26 Outlook
🚨 Price SensitiveFY25 Results and FY26 Outlook
FAQs
What does Appen do?
Appen supplies data annotation and training datasets for AI models.
Who are Appen clients?
Appen works with major technology and enterprise customers globally.
Why is APX volatile?
Revenue concentration and shifts in AI data demand can drive volatility.
Key Metrics
Related Stocks
Information Technology
BRNBrainchip Holdings Ltd
A$0.13
-51.9% 1Y
Brainchip develops neuromorphic AI processors designed for ultra-low power edge computing.
Information Technology
WBTWeebit Nano Ltd
A$5.13
190.7% 1Y
Weebit Nano develops advanced memory technology for next-generation semiconductor devices.
Information Technology
1TTThrive Tribe Technologies Limited
A$0.00
-97.5% 1Y
Thrive Tribe Technologies is an Australian technology company focused on the health and wellness sector. The company is developing its core product, the 'Thrive Tribe' platform, a digital application designed to connect individuals and build communities around shared health goals and interests. As a micro-cap entity, 1TT is in a very early, pre-commercialisation stage, having recently pivoted its strategy and changed its name from Ookami Limited.